Takuya Mima

Takuya Mima

Counsel

Tokyo

  • Language : Japanese, English
  • Mail : takuya.mima@tkilaw.com

EXPERIENCE

Dec. 2012-Dec.
2015, Kitahama Partners
2015
Eli Lilly Japan K.K., Legal Div. (secondee)
Jan. 2016-Dec.
2024, Nishimura & Asahi
Aug. 2022-Dec.
2023, Okada Law Firm (Hong Kong) (secondee)
Jan. 2024
FUJIFILM Holdings Corporation, Intellectual Property Div. (secondee)
Jan. 2025
Joined Tokyo International Law Office

QUALIFICATION

  • 2012 Japan (Daini Tokyo Bar Association)
  • 2023 New York, U.S.

EDUCATION

2009
LL.B., Kyoto University
2011
J.D., Kyoto University Law School
2022
LL.M., Business Law Certificate, Duke University School of Law

Publication

Oct. 2023
Co-Author, “Indonesia: Indonesian Healthcare Sector: Notable Highlights for Foreign Investors”, Nishimura & Asahi Newsletter (online article), (in English and Japanese).
Aug. 2023
Co-Author, “Vietnam: Overview of the distribution rule and advertising regulations for medical devices”, Nishimura & Asahi Newsletter (online article), (in English and Japanese).
Jul. 2023
Co-Author, “Vietnam: Overview of the national rule for Software of Medical Devices (SaMD)”, Nishimura & Asahi Newsletter (online article), (in English and Japanese).
2020
Co-Author, The International Comparative Legal Guide to: Pharmaceutical Advertising (Japan Chapter), Global Legal Group, 2020 edition (in English).
Oct. 2019
Author, “Revision to Patent Act in 2019”, International Law Office Newsletter (online article), (in English).
2019
Co-Author, “IP in Business Transactions Multi-Jurisdictional Guide: Japan Chapter”, Practical Law Company (online article), 2019 edition (in English).
2019
Co-Author, The International Comparative Legal Guide to: Pharmaceutical Advertising (Japan Chapter), Global Legal Group, 2019 edition (in English).